The risk of death with the new ORAL multiple sclerosis drug fingolimod (Gilenya) is too high to use it safely.

This is false.....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login